TipRanks
Advertisement
Advertisement

DE:DMP Stock Latest News

Dermapharm Rated Hold as Growth Normalizes and Risks Temper Upside; Price Target Reiterated at $44
RatingsDermapharm Rated Hold as Growth Normalizes and Risks Temper Upside; Price Target Reiterated at $44
1M ago
Dermapharm: Improving Margins but Modest Growth Outlook Leads Piasta to Reiterate Hold and Maintain $44 Price Target
PremiumRatings
Dermapharm: Improving Margins but Modest Growth Outlook Leads Piasta to Reiterate Hold and Maintain $44 Price Target
1M ago
Dermapharm: Hold Rating Reiterated as Execution Risks Temper Growth Outlook; Price Target Maintained at $44
PremiumRatings
Dermapharm: Hold Rating Reiterated as Execution Risks Temper Growth Outlook; Price Target Maintained at $44
2M ago
Hold Rating Maintained as Results Track Guidance; €44 Price Target Kept Unchanged
PremiumRatings
Hold Rating Maintained as Results Track Guidance; €44 Price Target Kept Unchanged
2M ago
Is DMP a Buy, Before Earnings?
PremiumPre-Earnings
Is DMP a Buy, Before Earnings?
5M ago
Fabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
PremiumRatingsFabian Piasta Reiterates Hold Rating and Keeps $34 Price Target as Improved Profitability Aligns With Expectations
5M ago
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
Premium
Ratings
Dermapharm: Muted Growth Outlook and Arkopharma Uncertainty Underpin Hold Rating
6M ago
Hold Rating Maintained on Dermapharm as Profitability Gains Offset by Weak Top-Line Momentum and Limited Near-Term Upside
Premium
Ratings
Hold Rating Maintained on Dermapharm as Profitability Gains Offset by Weak Top-Line Momentum and Limited Near-Term Upside
7M ago
Dermapharm Holding SE: Navigating Transitional Challenges and Strategic Opportunities
PremiumRatings
Dermapharm Holding SE: Navigating Transitional Challenges and Strategic Opportunities
1y ago
Balanced Hold Rating for Dermapharm Holding SE Amid Growth Prospects and Expansion Challenges
PremiumRatings
Balanced Hold Rating for Dermapharm Holding SE Amid Growth Prospects and Expansion Challenges
1y ago
Dermapharm Holding SE: Strong Financial Resilience and Growth Potential Amid Strategic Adjustments
PremiumRatings
Dermapharm Holding SE: Strong Financial Resilience and Growth Potential Amid Strategic Adjustments
1y ago
Dermapharm Holding SE (DMP) Reveals Q3 Dividend: Here’s the Essential Information
PremiumDividends
Dermapharm Holding SE (DMP) Reveals Q3 Dividend: Here’s the Essential Information
1y ago
Dermapharm Holding SE: Buy Rating Affirmed Amid Modest Growth and Strategic Realignment
PremiumRatingsDermapharm Holding SE: Buy Rating Affirmed Amid Modest Growth and Strategic Realignment
1y ago
Dermapharm Holding SE: Strong Q4 Performance and Margin Improvement Justify Buy Rating
Premium
Ratings
Dermapharm Holding SE: Strong Q4 Performance and Margin Improvement Justify Buy Rating
2y ago
Dermapharm Holding SE (DMP) Reveals Q3 Dividend: Here’s the Essential Information
Premium
Dividends
Dermapharm Holding SE (DMP) Reveals Q3 Dividend: Here’s the Essential Information
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >